James E. Bradner

Companies

• AmgenEVP, R&D, & Chief Sci. Officer Dec 19, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Amgen AMGN30,016 shares²$13.0M at $432.40May 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 7, 2026Shares withheld for tax 446 shares at $331.11 of Amgen²
• May 6, 2026Shares withheld for tax 407 shares at $329.59 of Amgen³
• May 5, 2026Granted 3,337 shares of Amgen³
• Feb 9, 2026Shares withheld for tax 953 shares at $384.32 of Amgen⁴
• Feb 9, 2026Shares withheld for tax 2,151 shares at $384.32 of Amgen⁴
• May 6, 2025Granted 3,549 shares of Amgen⁵
• May 7, 2024Granted 2,863 shares of Amgen⁶
• Feb 9, 2024Granted 13,806 shares of Amgen⁷
• Feb 9, 2024Granted 8,587 shares of Amgen⁷